A Tumor-Targeted Cascade Catalytic Nanoreactor for Microenvironment Remodeling and Photodynamic Immunotherapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42059243.
- Also identified by DOI 10.1002/adhm.71205.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypoxia, glutathione (GSH) overexpression, and lactate accumulation within the solid tumor microenvironment severely constrain the efficacy of photocatalytic therapy. Here, we report a CD44-targeted cascade nanoplatform (CNMLH) constructed via layer-by-layer assembly to remodel this metabolic barrier. The platform features a hollow graphitic carbon nitride (CN) core, sequentially coated with an in situ grown MnO<sub>2</sub> shell, an electrostatically adsorbed lactate oxidase (LOx) layer, and an outermost hyaluronic acid (HA) coating. Upon HA-mediated internalization, the outer coating degrades to release LOx, which selectively consumes lactate to produce H<sub>2</sub>O<sub>2</sub>. Subsequently, the exposed MnO<sub>2</sub> shell scavenges endogenous GSH and converts the generated H<sub>2</sub>O<sub>2</sub> into O<sub>2</sub>. This catalytic cascade effectively disrupts the tumor's antioxidant defense system and alleviates local hypoxia. Consequently, under subsequent light irradiation, the CN core overcomes the hypoxic restriction to efficiently generate reactive oxygen species (ROS), thereby triggering robust immunogenic cell death (ICD). Both in vitro and in vivo experimental results confirm that this metabolism-intervening strategy effectively reverses the immunosuppressive microenvironment while eliciting antitumor immune responses.